MoAs: SGLT2i, GLP-1 RAs, and GIP/GLP-1 RAs
Mechanisms of Action: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Receptor Coagonists

Released: November 07, 2023

Carol Hatch Wysham
Carol Hatch Wysham, MD

Activity

Progress
1
Course Completed